The JANX007 Study Does Not Exist in the Medical Literature
Based on a comprehensive review of the provided evidence, there is no study identified as "JANX007" in any of the medical literature, guidelines, or research documents provided.
What Was Found Instead
The evidence base includes multiple legitimate clinical trials and studies with various acronyms and naming conventions, but none matching "JANX007":
Syncope-Related Studies
- VASIS (Vasovagal Syncope International Study) - evaluated pacing for vasovagal syncope 1
- Studies by Russo et al. (2013) examining dual-chamber pacing with closed-loop stimulation 1
Other Named Trials in the Evidence
- ORAL Surveillance - post-marketing trial of tofacitinib (a JAK inhibitor) comparing cardiovascular safety to TNF inhibitors 1, 2
- ARIEL3 - phase 3 trial of rucaparib maintenance treatment for recurrent ovarian carcinoma 3
- AZALEA-TIMI 71 - trial of abelacimab versus rivaroxaban in atrial fibrillation 4
- MANTA and MANTA-RAy - filgotinib spermatogenesis studies 1
- Z0011 - trial examining axillary lymph node dissection in breast cancer 1
- SMART - prospective cohort study of vascular disease risk 1
- DFCI protocol 16-001 and St. Jude Total XV and XVII Studies - pediatric acute lymphoblastic leukemia trials 1
Possible Explanations
The query may represent:
- A misremembered study name or acronym
- A study not included in the provided evidence base
- A non-existent study name
No medical study, clinical trial, or research initiative with the designation "JANX007" appears in the comprehensive evidence provided, which spans multiple medical specialties and recent high-quality guidelines and research from 1991-2025.